MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/13993003.00142-2021

Медицинская библиотека · The European respiratory journal · 2022

Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.

Sparreman Mikus Maria, Kolmert Johan, Andersson Lars I, Östling Jörgen, Knowles Richard G, Gómez Cristina, Ericsson Magnus, Thörngren John-Olof, Emami Khoonsari Payam, Dahlén Barbro, Kupczyk Maciej, De Meulder Bertrand, Auffray Charles, Bakke Per S, Beghe Bianca, Bel Elisabeth H, Caruso Massimo, Chanez Pascal, Chawes Bo, Fowler Stephen J, Gaga Mina, Geiser Thomas, Gjomarkaj Mark, Horváth Ildikó, Howarth Peter H, Johnston Sebastian L, Joos Guy, Krug Norbert, Montuschi Paolo, Musial Jacek, Niżankowska-Mogilnicka Ewa, Olsson Henric K, Papi Alberto, Rabe Klaus F, Sandström Thomas, Shaw Dominick E, Siafakas Nikolaos M, Uhlén Mathias, Riley John H, Bates Stewart, Middelveld Roelinde J M, Wheelock Craig E, Chung Kian Fan, Adcock Ian M, Sterk Peter J, Djukanovic Ratko, Nilsson Peter, Dahlén Sven-Erik, James Anna, U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease outcome) Study Group and the BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium

Контролируемое клиническое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

RATIONALE: Asthma phenotyping requires novel biomarker discovery.

OBJECTIVES

To identify plasma biomarkers associated with asthma phenotypes by application of a new proteomic panel to samples from two well-characterised cohorts of severe (SA) and mild-to-moderate (MMA) asthmatics, COPD subjects and healthy controls (HCs).

METHODS

An antibody-based array targeting 177 proteins predominantly involved in pathways relevant to inflammation, lipid metabolism, signal transduction and extracellular matrix was applied to plasma from 525 asthmatics and HCs in the U-BIOPRED cohort, and 142 subjects with asthma and COPD from the validation cohort BIOAIR. Effects of oral corticosteroids (OCS) were determined by a 2-week, placebo-controlled OCS trial in BIOAIR, and confirmed by relation to objective OCS measures in U-BIOPRED.

RESULTS

In U-BIOPRED, 110 proteins were significantly different, mostly elevated, in SA compared to MMA and HCs. 10 proteins were elevated in SA versus MMA in both U-BIOPRED and BIOAIR (alpha-1-antichymotrypsin, apolipoprotein-E, complement component 9, complement factor I, macrophage inflammatory protein-3, interleukin-6, sphingomyelin phosphodiesterase 3, TNF receptor superfamily member 11a, transforming growth factor-β and glutathione S-transferase). OCS treatment decreased most proteins, yet differences between SA and MMA remained following correction for OCS use. Consensus clustering of U-BIOPRED protein data yielded six clusters associated with asthma control, quality of life, blood neutrophils, high-sensitivity C-reactive protein and body mass index, but not Type-2 inflammatory biomarkers. The mast cell specific enzyme carboxypeptidase A3 was one major contributor to cluster differentiation.

CONCLUSIONS

The plasma proteomic panel revealed previously unexplored yet potentially useful Type-2-independent biomarkers and validated several proteins with established involvement in the pathophysiology of SA.

Для цитирования: Sparreman Mikus Maria, Kolmert Johan, Andersson Lars I, Östling Jörgen, Knowles Richard G, Gómez Cristina, Ericsson Magnus, Thörngren John-Olof, Emami Khoonsari Payam, Dahlén Barbro, Kupczyk Maciej, De Meulder Bertrand, Auffray Charles, Bakke Per S, Beghe Bianca, Bel Elisabeth H, Caruso Massimo, Chanez Pascal, Chawes Bo, Fowler Stephen J, Gaga Mina, Geiser Thomas, Gjomarkaj Mark, Horváth Ildikó, Howarth Peter H, Johnston Sebastian L, Joos Guy, Krug Norbert, Montuschi Paolo, Musial Jacek, Niżankowska-Mogilnicka Ewa, Olsson Henric K, Papi Alberto, Rabe Klaus F, Sandström Thomas, Shaw Dominick E, Siafakas Nikolaos M, Uhlén Mathias, Riley John H, Bates Stewart, Middelveld Roelinde J M, Wheelock Craig E, Chung Kian Fan, Adcock Ian M, Sterk Peter J, Djukanovic Ratko, Nilsson Peter, Dahlén Sven-Erik, James Anna, U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease outcome) Study Group and the BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.. The European respiratory journal. 2022. DOI: 10.1183/13993003.00142-2021.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.